TY - JOUR T1 - Longitudinal changes in age and race of patients with SARS-CoV-2 in a multi-hospital health system JF - medRxiv DO - 10.1101/2021.08.16.21262016 SP - 2021.08.16.21262016 AU - Ian J. Barbash AU - Lee H. Harrison AU - Jana L. Jacobs AU - Faraaz Ali Shah AU - Tomeka L. Suber AU - Kevin L. Quinn AU - Oscar C. Marroquin AU - Mark T. Gladwin AU - Rachel E. Sackrowitz AU - Alison Morris Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/08/18/2021.08.16.21262016.abstract N2 - Background The COVID-19 pandemic continues to affect the United States and the world. Media reports have suggested that the wave of the alpha variant in the Spring of 2021 in the US caused more cases among younger patients and racial and ethnic subgroups.Approach We analyzed electronic health record data from a multihospital health system to test whether younger patients accounted for more cases and more severe disease, and whether racial disparities are widening. We compared demographics, patient characteristics, and hospitalization variables for patients admitted from November 2020 through January 2021 to those admitted in March and April 2021.Results We analyzed data for 37, 502 unique inpatients and outpatients at 21 hospitals from November 1, 2020 to April 30, 2021. Compared to patients from November through January, those with positive tests in March and April were younger and less likely to die. Among patients under age 50, those with positive tests in March and April were three times as likely to be hospitalized and twice as likely to require ICU admission or mechanical ventilation. Individuals identified as Black represented a greater proportion of cases and hospitalizations in March and April as compared to November through January.Conclusions We found that relative COVID-19 hospitalization rates for younger individuals and individuals identified as Black were rising over time. These findings have important implications for ongoing public health measures to mitigate the impact of the pandemic.Competing Interest StatementDrs. Barbash, Harrison, Shah, Suber, Marroquin, Gladwin, Sackrowitz, and Morris are employed in part by the UPMC Health SystemFunding StatementSupported in part by K08HS025455 from AHRQ (to Dr. Barbash). The funding agency played no role in the design or conduct of the study or the decision to submit for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was reviewed and approved by the University of Pittsburgh Human Research Protection Office. IRB MOD20040114-006.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesBecause the data come from the UPMC Health System, access to the data would require a DUA executed with the University of Pittsburgh IRB and UPMC ER -